FI961000A - Embodiments of myelin oligodendrocyte glycoprotein and peptide portions thereof in autoimmune disease method - Google Patents
Embodiments of myelin oligodendrocyte glycoprotein and peptide portions thereof in autoimmune disease method Download PDFInfo
- Publication number
- FI961000A FI961000A FI961000A FI961000A FI961000A FI 961000 A FI961000 A FI 961000A FI 961000 A FI961000 A FI 961000A FI 961000 A FI961000 A FI 961000A FI 961000 A FI961000 A FI 961000A
- Authority
- FI
- Finland
- Prior art keywords
- autoimmune disease
- myelin oligodendrocyte
- oligodendrocyte glycoprotein
- peptide portions
- disease method
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Diabetes (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Toxicology (AREA)
- Rehabilitation Therapy (AREA)
- Cell Biology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11682493A | 1993-09-03 | 1993-09-03 | |
PCT/US1994/010257 WO1995006727A2 (en) | 1993-09-03 | 1994-09-01 | Uses of myelin oligodendrocyte glycoprotein and peptide portions thereof in protocols related to autoimmune disease |
Publications (2)
Publication Number | Publication Date |
---|---|
FI961000A0 FI961000A0 (en) | 1996-03-04 |
FI961000A true FI961000A (en) | 1996-03-04 |
Family
ID=22369451
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI961000A FI961000A (en) | 1993-09-03 | 1996-03-04 | Embodiments of myelin oligodendrocyte glycoprotein and peptide portions thereof in autoimmune disease method |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0716696A1 (en) |
JP (1) | JPH09502346A (en) |
KR (1) | KR960705038A (en) |
AU (1) | AU7725894A (en) |
CA (1) | CA2170901A1 (en) |
FI (1) | FI961000A (en) |
NO (1) | NO960858D0 (en) |
NZ (1) | NZ273813A (en) |
WO (1) | WO1995006727A2 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU4278296A (en) * | 1994-10-25 | 1996-05-15 | Immulogic Pharmaceutical Corporation | Compositions and treatment for multiple sclerosis |
DE69637391T2 (en) * | 1995-05-02 | 2008-08-14 | Alexion Pharmaceuticals, Inc., Cheshire | MODIFIED MYELIN PROTEIN MOLECULES |
CA2250361A1 (en) * | 1996-03-28 | 1997-10-02 | Barbara Wallner | Myelin oligodendrocyte glycoprotein peptides and uses thereof |
WO1998033912A1 (en) * | 1997-01-30 | 1998-08-06 | Human Genome Sciences, Inc. | MYELIN OLIGODENDROCYTE GLYCOPROTEIN-LIKE PROTEIN (MOGp) AND METHODS OF USE |
SE9703287D0 (en) * | 1997-09-11 | 1997-09-11 | Astra Ab | Peptides |
ZA9810133B (en) * | 1997-11-07 | 1999-05-17 | Biogen Inc | BMOG a novel protein member of the myelin-oligodendrocyte glycoprotein family and its use for ummonomodulatory purposes |
EP1115425B1 (en) * | 1998-08-26 | 2007-03-21 | The Regents of the University of California | Autoantibody inhibitors |
CN1301756A (en) * | 1999-12-29 | 2001-07-04 | 复旦大学 | New polypeptide-myelin PO protein 14 and polynucleotide coding such polypeptide |
CN1352087A (en) * | 2000-11-02 | 2002-06-05 | 上海博德基因开发有限公司 | New polypeptide-human glycoprotein 42 and polynucleotide for encoding such polypeptide |
WO2007008933A2 (en) * | 2005-07-11 | 2007-01-18 | Carantech Biosciences, Inc. | Compositions and methods comprising complex alternative splice variants of myelin/oligodendrocyte genes (mogs) and antibodies directed thereto |
CN101897964B (en) * | 2009-04-27 | 2013-04-10 | 中国农业大学 | Medicament for preventing autoimmune disease |
WO2013020914A1 (en) * | 2011-08-10 | 2013-02-14 | Celares Gmbh | Peg-conjugated peptides |
GB201300684D0 (en) * | 2013-01-15 | 2013-02-27 | Apitope Int Nv | Peptide |
AU2015249328B2 (en) * | 2014-04-24 | 2019-01-17 | University Of Florida Research Foundation, Inc. | AAV-based gene therapy for multiple sclerosis |
CN110536901B (en) | 2016-12-26 | 2024-06-18 | 协和麒麟株式会社 | Antibodies that bind myelin oligodendrocyte glycoprotein |
US11334352B1 (en) | 2020-12-29 | 2022-05-17 | Kpn Innovations, Llc. | Systems and methods for generating an immune protocol for identifying and reversing immune disease |
-
1994
- 1994-09-01 AU AU77258/94A patent/AU7725894A/en not_active Abandoned
- 1994-09-01 EP EP94928084A patent/EP0716696A1/en not_active Withdrawn
- 1994-09-01 JP JP7508328A patent/JPH09502346A/en active Pending
- 1994-09-01 CA CA002170901A patent/CA2170901A1/en not_active Abandoned
- 1994-09-01 KR KR1019960701093A patent/KR960705038A/en not_active Application Discontinuation
- 1994-09-01 WO PCT/US1994/010257 patent/WO1995006727A2/en not_active Application Discontinuation
- 1994-09-01 NZ NZ273813A patent/NZ273813A/en unknown
-
1996
- 1996-03-01 NO NO960858A patent/NO960858D0/en unknown
- 1996-03-04 FI FI961000A patent/FI961000A/en unknown
Also Published As
Publication number | Publication date |
---|---|
NO960858L (en) | 1996-03-01 |
FI961000A0 (en) | 1996-03-04 |
JPH09502346A (en) | 1997-03-11 |
NZ273813A (en) | 1998-05-27 |
AU7725894A (en) | 1995-03-22 |
WO1995006727A2 (en) | 1995-03-09 |
CA2170901A1 (en) | 1995-03-09 |
KR960705038A (en) | 1996-10-09 |
NO960858D0 (en) | 1996-03-01 |
WO1995006727A3 (en) | 1995-04-13 |
EP0716696A1 (en) | 1996-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI961000A (en) | Embodiments of myelin oligodendrocyte glycoprotein and peptide portions thereof in autoimmune disease method | |
DE69535031D1 (en) | Selective acylation of epsilon-amino groups in insulin | |
FI944881A0 (en) | Procedure and arrangements for the dissemination of information | |
FI954559A0 (en) | YY peptide analogues and their uses | |
KR950702113A (en) | AMINIMIDE-CONTAINING MOLECULES AND MATERIALS AS MOLECULAR RECOGNITION AGENTS | |
FI952656A0 (en) | Foerfarande and anordning vid pulsmaetning av en person | |
EP0967992A4 (en) | Peptide vaccine to prevent development of several herpes virus infections and/or atherosclerotic plaque | |
BR9707613A (en) | Mixtures free of polypholic derivatives process of preparing mixtures i and ii medications and use of mixtures | |
EP0729300A4 (en) | Novel fas protein and methods of use thereof | |
ITTO910205A0 (en) | PRODUCTION OF HIGH TENACITY AND LOW SHRINKAGE POLYESTER FIBER. | |
BR9708505A (en) | Injection process or model and co-injection process | |
IT1227268B (en) | IMPROVEMENT IN BATHTUBS AND PROCEDURE FOR THEIR MANUFACTURE | |
KR940027054U (en) | Combined structure of motor set and motor | |
ITMI931334A0 (en) | COMPATIBLE POLYMER MIXTURES OF POLYCARBONATE AND POLYAMIDES | |
AU7731398A (en) | Uses of myelin oligodendrocyte glycoprotein and peptide portions thereof in protocols related to autoimmune disease | |
KR970011924U (en) | Car key and its storage case | |
BR9202682A (en) | POLYESTER RECLINING AND BENEFIT PROCESS | |
BR9500143A (en) | Process of thermogenesis and oxygenation | |
BR9403296A (en) | Freeze-drying process of lemon juice and instant caipirinha kit | |
KR970023239U (en) | Combined structure of fender liner and fender | |
NO932538D0 (en) | REGISTRATION OF SUBSTANCES IN VASKE | |
KR970004602U (en) | Tire Extruded Shrinkage and Conveyer | |
FR2735973B1 (en) | INFLATABLE ANTI-EQUINE AND ANTI-DECARRE BOOT | |
KR950015229U (en) | Car audio with preset scan and scan at power-on | |
KR950017245U (en) | Assembly structure of main core and split core of injection mold |